Kartolo, A.; Deluce, J.; Hopman, W.M.; Liu, L.; Baetz, T.; Ernst, S.; Lenehan, J.G.
Real-World Evidence of Systemic Therapy Sequencing on Overall Survival for Patients with Metastatic BRAF-Mutated Cutaneous Melanoma. Curr. Oncol. 2022, 29, 1501-1513.
https://doi.org/10.3390/curroncol29030126
AMA Style
Kartolo A, Deluce J, Hopman WM, Liu L, Baetz T, Ernst S, Lenehan JG.
Real-World Evidence of Systemic Therapy Sequencing on Overall Survival for Patients with Metastatic BRAF-Mutated Cutaneous Melanoma. Current Oncology. 2022; 29(3):1501-1513.
https://doi.org/10.3390/curroncol29030126
Chicago/Turabian Style
Kartolo, Adi, Jasna Deluce, Wilma M. Hopman, Linda Liu, Tara Baetz, Scott Ernst, and John G. Lenehan.
2022. "Real-World Evidence of Systemic Therapy Sequencing on Overall Survival for Patients with Metastatic BRAF-Mutated Cutaneous Melanoma" Current Oncology 29, no. 3: 1501-1513.
https://doi.org/10.3390/curroncol29030126
APA Style
Kartolo, A., Deluce, J., Hopman, W. M., Liu, L., Baetz, T., Ernst, S., & Lenehan, J. G.
(2022). Real-World Evidence of Systemic Therapy Sequencing on Overall Survival for Patients with Metastatic BRAF-Mutated Cutaneous Melanoma. Current Oncology, 29(3), 1501-1513.
https://doi.org/10.3390/curroncol29030126
